A citation-based method for searching scientific literature

Zheng Liu, Anne Davidson. Nat Med 2012
Times Cited: 238







List of co-cited articles
739 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Systemic lupus erythematosus.
George C Tsokos. N Engl J Med 2011
19

Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.
Richard Furie, Munther Khamashta, Joan T Merrill, Victoria P Werth, Kenneth Kalunian, Philip Brohawn, Gabor G Illei, Jorn Drappa, Liangwei Wang, Stephen Yoo. Arthritis Rheumatol 2017
332
12

Systemic lupus erythematosus.
Anisur Rahman, David A Isenberg. N Engl J Med 2008
11

Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.
Lynda Bennett, A Karolina Palucka, Edsel Arce, Victoria Cantrell, Josef Borvak, Jacques Banchereau, Virginia Pascual. J Exp Med 2003
10

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus.
Emily C Baechler, Franak M Batliwalla, George Karypis, Patrick M Gaffney, Ward A Ortmann, Karl J Espe, Katherine B Shark, William J Grande, Karis M Hughes, Vivek Kapur,[...]. Proc Natl Acad Sci U S A 2003
10


What is damaging the kidney in lupus nephritis?
Anne Davidson. Nat Rev Rheumatol 2016
105
8

Systemic lupus erythematosus disease activity index 2000.
Dafna D Gladman, Dominique Ibañez, Murray B Urowitz. J Rheumatol 2002
8

Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.
Michelle Petri, Ana-Maria Orbai, Graciela S Alarcón, Caroline Gordon, Joan T Merrill, Paul R Fortin, Ian N Bruce, David Isenberg, Daniel J Wallace, Ola Nived,[...]. Arthritis Rheum 2012
8

New insights into the immunopathogenesis of systemic lupus erythematosus.
George C Tsokos, Mindy S Lo, Patricia Costa Reis, Kathleen E Sullivan. Nat Rev Rheumatol 2016
341
8


Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial.
Sandra V Navarra, Renato M Guzmán, Alberto E Gallacher, Stephen Hall, Roger A Levy, Renato E Jimenez, Edmund K-M Li, Mathew Thomas, Ho-Youn Kim, Manuel G León,[...]. Lancet 2011
911
6

Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study.
Munther Khamashta, Joan T Merrill, Victoria P Werth, Richard Furie, Kenneth Kalunian, Gabor G Illei, Jorn Drappa, Liangwei Wang, Warren Greth. Ann Rheum Dis 2016
244
6

SLE peripheral blood B cell, T cell and myeloid cell transcriptomes display unique profiles and each subset contributes to the interferon signature.
Amy M Becker, Kathryn H Dao, Bobby Kwanghoon Han, Roger Kornu, Shuchi Lakhanpal, Angela B Mobley, Quan-Zhen Li, Yun Lian, Tianfu Wu, Andreas M Reimold,[...]. PLoS One 2013
106
6

Normalization of CD4+ T cell metabolism reverses lupus.
Yiming Yin, Seung-Chul Choi, Zhiwei Xu, Daniel J Perry, Howard Seay, Byron P Croker, Eric S Sobel, Todd M Brusko, Laurence Morel. Sci Transl Med 2015
267
6

Development of autoantibodies before the clinical onset of systemic lupus erythematosus.
Melissa R Arbuckle, Micah T McClain, Mark V Rubertone, R Hal Scofield, Gregory J Dennis, Judith A James, John B Harley. N Engl J Med 2003
6

Systemic lupus erythematosus.
Arvind Kaul, Caroline Gordon, Mary K Crow, Zahi Touma, Murray B Urowitz, Ronald van Vollenhoven, Guillermo Ruiz-Irastorza, Graham Hughes. Nat Rev Dis Primers 2016
231
6

The 1982 revised criteria for the classification of systemic lupus erythematosus.
E M Tan, A S Cohen, J F Fries, A T Masi, D J McShane, N F Rothfield, J G Schaller, N Talal, R J Winchester. Arthritis Rheum 1982
6

Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial.
Daniel J Wallace, Richard A Furie, Yoshiya Tanaka, Kenneth C Kalunian, Marta Mosca, Michelle A Petri, Thomas Dörner, Mario H Cardiel, Ian N Bruce, Elisa Gomez,[...]. Lancet 2018
148
6

Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures.
Laurent Chiche, Noémie Jourde-Chiche, Elizabeth Whalen, Scott Presnell, Vivian Gersuk, Kristen Dang, Esperanza Anguiano, Charlie Quinn, Stéphane Burtey, Yvon Berland,[...]. Arthritis Rheumatol 2014
162
5

RNA sensing by conventional dendritic cells is central to the development of lupus nephritis.
Teja Celhar, Richard Hopkins, Susannah I Thornhill, Raquel De Magalhaes, Sun-Hee Hwang, Hui-Yin Lee, Hiroko Yasuga, Leigh A Jones, Jose Casco, Bernett Lee,[...]. Proc Natl Acad Sci U S A 2015
33
15

Autoreactive B cell responses to RNA-related antigens due to TLR7 gene duplication.
Prapaporn Pisitkun, Jonathan A Deane, Michael J Difilippantonio, Tatyana Tarasenko, Anne B Satterthwaite, Silvia Bolland. Science 2006
558
5

Induction of autoimmunity by pristane and other naturally occurring hydrocarbons.
Westley H Reeves, Pui Y Lee, Jason S Weinstein, Minoru Satoh, Li Lu. Trends Immunol 2009
199
5

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus.
Richard Furie, Michelle Petri, Omid Zamani, Ricard Cervera, Daniel J Wallace, Dana Tegzová, Jorge Sanchez-Guerrero, Andreas Schwarting, Joan T Merrill, W Winn Chatham,[...]. Arthritis Rheum 2011
715
5

Sifalimumab, a human anti-interferon-α monoclonal antibody, in systemic lupus erythematosus: a phase I randomized, controlled, dose-escalation study.
Michelle Petri, Daniel J Wallace, Alberto Spindler, Vishala Chindalore, Kenneth Kalunian, Eduardo Mysler, C Michael Neuwelt, Gabriel Robbie, Wendy I White, Brandon W Higgs,[...]. Arthritis Rheum 2013
170
5


High serum IFN-alpha activity is a heritable risk factor for systemic lupus erythematosus.
T B Niewold, J Hua, T J A Lehman, J B Harley, M K Crow. Genes Immun 2007
265
5

Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines.
Alenka Kuznik, Mojca Bencina, Urban Svajger, Matjaz Jeras, Blaz Rozman, Roman Jerala. J Immunol 2011
324
5

T follicular helper (Tfh) cells in lupus: Activation and involvement in SLE pathogenesis.
Patrick Blanco, Hideki Ueno, Nathalie Schmitt. Eur J Immunol 2016
70
7

Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases.
Daxing Gao, Tuo Li, Xiao-Dong Li, Xiang Chen, Quan-Zhen Li, Mary Wight-Carter, Zhijian J Chen. Proc Natl Acad Sci U S A 2015
266
5

Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus.
Joerg Wenzel, Eva Wörenkämper, Silke Freutel, Stefanie Henze, Otto Haller, Thomas Bieber, Thomas Tüting. J Pathol 2005
146
5

Deregulated type I IFN response in TREX1-associated familial chilblain lupus.
Katrin Peschke, Franziska Friebe, Nick Zimmermann, Tom Wahlicht, Tina Schumann, Martin Achleitner, Nicole Berndt, Hella Luksch, Rayk Behrendt, Min Ae Lee-Kirsch,[...]. J Invest Dermatol 2014
25
20

Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus.
Simone Caielli, Shruti Athale, Bojana Domic, Elise Murat, Manjari Chandra, Romain Banchereau, Jeanine Baisch, Kate Phelps, Sandra Clayton, Mei Gong,[...]. J Exp Med 2016
176
5

Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9.
Terry K Means, Eicke Latz, Fumitaka Hayashi, Mandakolathur R Murali, Douglas T Golenbock, Andrew D Luster. J Clin Invest 2005
511
5

Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus.
Jing He, Xia Zhang, Yunbo Wei, Xiaolin Sun, Yaping Chen, Jun Deng, Yuebo Jin, Yuzhou Gan, Xin Hu, Rulin Jia,[...]. Nat Med 2016
229
5


Immunometabolism in systemic lupus erythematosus.
Laurence Morel. Nat Rev Rheumatol 2017
88
5

American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis.
Bevra H Hahn, Maureen A McMahon, Alan Wilkinson, W Dean Wallace, David I Daikh, John D Fitzgerald, George A Karpouzas, Joan T Merrill, Daniel J Wallace, Jinoos Yazdany,[...]. Arthritis Care Res (Hoboken) 2012
664
5

The global burden of SLE: prevalence, health disparities and socioeconomic impact.
Erin E Carter, Susan G Barr, Ann E Clarke. Nat Rev Rheumatol 2016
123
5

Microtubule-associated protein 1 light chain 3 alpha (LC3)-associated phagocytosis is required for the efficient clearance of dead cells.
Jennifer Martinez, Johann Almendinger, Andrew Oberst, Rachel Ness, Christopher P Dillon, Patrick Fitzgerald, Michael O Hengartner, Douglas R Green. Proc Natl Acad Sci U S A 2011
373
4

Pathogenesis of systemic lupus erythematosus.
C C Mok, C S Lau. J Clin Pathol 2003
424
4

Safety profile and clinical activity of sifalimumab, a fully human anti-interferon α monoclonal antibody, in systemic lupus erythematosus: a phase I, multicentre, double-blind randomised study.
Joan T Merrill, Daniel J Wallace, Michelle Petri, Kyriakos A Kirou, Yihong Yao, Wendy I White, Gabriel Robbie, Robert Levin, Seth M Berney, Vishala Chindalore,[...]. Ann Rheum Dis 2011
166
4

Noncanonical autophagy inhibits the autoinflammatory, lupus-like response to dying cells.
Jennifer Martinez, Larissa D Cunha, Sunmin Park, Mao Yang, Qun Lu, Robert Orchard, Quan-Zhen Li, Mei Yan, Laura Janke, Cliff Guy,[...]. Nature 2016
210
4

Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation.
Jonathan A Deane, Prapaporn Pisitkun, Rebecca S Barrett, Lionel Feigenbaum, Terrence Town, Jerrold M Ward, Richard A Flavell, Silvia Bolland. Immunity 2007
319
4

The BAFF/APRIL system in SLE pathogenesis.
Fabien B Vincent, Eric F Morand, Pascal Schneider, Fabienne Mackay. Nat Rev Rheumatol 2014
202
4

A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus.
Robert R Graham, Sergey V Kozyrev, Emily C Baechler, M V Prasad Linga Reddy, Robert M Plenge, Jason W Bauer, Ward A Ortmann, Thearith Koeuth, Ma Francisca González Escribano, Bernardo Pons-Estel,[...]. Nat Genet 2006
455
4

A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-α) in patients with systemic lupus erythematosus (ROSE).
Kenneth C Kalunian, Joan T Merrill, Romeo Maciuca, Jacqueline M McBride, Michael J Townsend, Xiaohui Wei, John C Davis, William P Kennedy. Ann Rheum Dis 2016
189
4

Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.
Brandon W Higgs, Zheng Liu, Barbara White, Wei Zhu, Wendy I White, Chris Morehouse, Philip Brohawn, Peter A Kiener, Laura Richman, David Fiorentino,[...]. Ann Rheum Dis 2011
194
4

IFN-γ receptor and STAT1 signaling in B cells are central to spontaneous germinal center formation and autoimmunity.
Phillip P Domeier, Sathi Babu Chodisetti, Chetna Soni, Stephanie L Schell, Melinda J Elias, Eric B Wong, Timothy K Cooper, Daisuke Kitamura, Ziaur S M Rahman. J Exp Med 2016
89
4



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.